Salarius Pharmaceuticals Value At Risk
| SLRXDelisted Stock | | | USD 0.82 0.05 6.49% |
The Value At Risk indicator for Salarius Pharmaceuticals is constructed from normalized market data. All inputs reflect available trading data across supported markets. Some instruments may report limited inputs depending on trading history. Related indicator context is organized within
Equity Screeners. Salarius Pharmaceuticals has a market cap of 3.81 M, ROE of -139.55%. Use
World Market Map to explore allocation context. The allocation summary reflects available position data. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
Salarius Pharmaceuticals has current Value At Risk of
-16.92. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -16.92 | |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Salarius Pharmaceuticals is rated
below average in value at risk among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Other Technical Indicators